Drug company hands patents off to Native American tribe to avoid challenge

September 13, 2017

Enlarge / The administration and community building of the St. Regis Mohawk Tribe. (credit: P199 via Wikimedia)

A drug company has found a novel way to avoid challenges to some of its most prized patents: handing them off to a Native American tribe for safe-keeping.

On Friday, Allergan disclosed that it gave six patents covering its top-selling dry eye drug Restasis to the St. Regis Mohawk Tribe in Northern New York. The deal will provide the tribe with $13.75 million immediately and an annual royalty of $15 million as long as the patents are valid. The new deal was soon reported in both The New York Times and The Wall Street Journal. 

Allergan made the unprecedented move because it will prevent any meaningful challenge to the company’s patents at the Patent Trial and Appeal Board, or PTAB. Challenging patents at the PTAB in a process called “inter partes review” (IPR) was authorized by the America Invents Act of 2011, and the IPR process has significantly changed the patent landscape since then. While invalidating a patent in district court typically costs millions of dollars, invalidating a patent via IPR can happen for the relative bargain of a few hundred thousand dollars.

Read 10 remaining paragraphs | Comments

Source: http://feeds.arstechnica.com/arstechnica/index/

Da Feed

Author: Da Feed

The Charles Tendell Show aggregates the best content from all over the web. Check out the latest in tech, politics, and more at thecharlestendellshow.com/news. Get your own website added to the feed by contacting us today!

Comments are closed.

© 2016 The Charles Tendell Show